Preoperative Biomarkers as Prognostic Factors for Postoperative Upgrading in Prostate Cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034653

Enrollment

8000

Registered

2024-07-18

Start date

2024-02-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C61

Interventions

Group 1: Patients with prostate cancer who are being treated with radical prostatectomy. Patients will be enrolled in this prospective study at the time of the prostatectomy. Follow-ups will be conduc

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Prostate cancer Radical Prostatectomy Available clinical data

Exclusion criteria

Exclusion criteria: No prostate cancer No clinical data

Design outcomes

Primary

Measure	Time frame
Influence of standard laboratory biomarkers (leukocytes, CRP, platelets) on upstaging after surgery	—

Secondary

Measure	Time frame
Influence of preoperative diagnostics (MRI, fusion biopsy, PIRADS score) on upstaging after surgery	—

Countries

Germany

Contacts

Public ContactSeverin Rodler

Klinikum der Universität München

severin.rodler@med.uni-muenchen.de+49 89 4400 0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026